Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells-Reference-Cited by-同舟云学术

Oral Hsp90 inhibitor SNX-5422 attenuates SARS-CoV-2 replication and dampens inflammation in airway cells

Published:2021-12 Issue:12 Volume:24 Page:103412
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Goswami Ria^ORCID,Russell Veronica S.^ORCID,Tu Joshua J.^ORCID,Thomas Charlene^ORCID,Hughes Philip^ORCID,Kelly Francine,Langel Stephanie N.,Steppe Justin,Palmer Scott M.,Haystead Timothy,Blasi Maria,Permar Sallie R.

Funder

Open Philanthropy Project

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference83 articles.

1. Regulatory cross talk between SARS-CoV-2 receptor binding and replication machinery in the human host;Ahmed;Front. Physiol.,2020

2. Remdesivir for the treatment of Covid-19 - final report;Beigel;N. Engl. J. Med.,2020

3. Imbalanced host response to SARS-CoV-2 drives development of COVID-19;Blanco-Melo;Cell,2020

4. The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism;Blasco;Sci. Rep.,2020

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication;Signal Transduction and Targeted Therapy;2024-06-28

2. MONFIT: Multi-omics factorization-based integration of time-series data sheds light on Parkinson’s disease;2024-06-03

3. Protective role of the HSP90 inhibitor, STA-9090, in lungs of SARS-CoV-2-infected Syrian golden hamsters;BMJ Open Respiratory Research;2024-02

4. Differential activation of programmed cell death in patients with severe SARS-CoV-2 infection;Cell Death Discovery;2023-11-20

5. HSP90, a Common Therapeutic Target for Suppressing Skin Injury Caused by Exposure to Chemically Diverse Classes of Blistering Agents;Journal of Pharmacology and Experimental Therapeutics;2023-11-01